发明名称 INHIBITION OF CANDIDA
摘要 2089665 9203455 PCTABS00010 Compositions and methods are provided for the treatment and diagnosis of Candida infections. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with at least a portion of a Candida mRNA. Preferred targets are the mRNAs which encode .beta.-tubulin, aspartate protease, actin and chitin synthetase, as well as the mRNA's which encode the ribosomal L25 protein, translation elongation factors 1 and 2 (TEF1 and TEF2), the b subunit of ATPase, and cytochrome P450 lanosterol 14.alpha.-demethylase (L1A1). The oligonucleotides and oligonucleotide analogs comprise nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a transcription initiation site, a translation initiation site, 5'-untranslated sequences, 3'-untranslated sequences, 5'-cap, and intron/exon junct ion of the mRNAs. Methods of treating animals suffering from Candida infection are disclosed.
申请公布号 CA2089665(A1) 申请公布日期 1992.02.17
申请号 CA19912089665 申请日期 1991.08.15
申请人 ISIS PHARMACEUTICALS, INC. 发明人 HOKE, GLENN D.;ECKER, DAVID J.
分类号 A61K31/70;A61K38/00;A61K48/00;A61P31/04;C07K14/39;C12N15/09;C12N15/113;(IPC1-7):C07H21/00 主分类号 A61K31/70
代理机构 代理人
主权项
地址